What clinical trials are available for recurrent Prostate Cancer

Clinical Trials for Recurrent Prostate Cancer

I appreciate your question about clinical trial options. Based on the educational resources available, I can share important information about how trials are being used in prostate cancer care, though I should note that specific trial availability changes frequently and depends on your individual situation.

Current Trial Approaches Being Studied

According to the CancerPatientLab webinar on "Update on Immunotherapies for Metastatic Castrate Resistant Prostate Cancer" featuring Dr. [removed] Subudhi, several promising trial approaches are actively being investigated:

Immunotherapy-Based Trials

T-cell Bispecifics - These are emerging as a major focus. Dr. [removed] notes that "the backbone of immunotherapy treatments in prostate cancer will likely be T-cell bispecifics," where one part of the drug recognizes cancer cells and another part activates your immune system's T-cells to attack them.

Combination Immunotherapy Trials - Research is exploring combinations such as:

• Immune checkpoint inhibitors (like anti-PD-L1 and anti-CTLA-4 therapies)
• CAR T-cells targeted at PSMA (prostate-specific membrane antigen)
• Vaccines combined with immunotherapy

Bipolar Androgen Therapy (BAT) Trials - According to the webinar on "Bipolar Androgen Therapy for Prostate Cancer" by Dr. [removed] Antonarakis, BAT involves cycling testosterone levels and is being studied in trials like ExBAT, which combines BAT with the drug darolutamide. The COMBAT trial combined BAT with nivolumab (an immune checkpoint inhibitor), showing a 40% PSA50 response rate.

Radiation + Immunotherapy Combinations

Emerging research is exploring lower-dose radiation therapy combined with immunotherapy to boost immune system effectiveness, rather than using high-dose radiation alone.

---

How to Find Trials Relevant to YOUR Situation

The most important point: Trial availability depends on:

• Your specific genetic/molecular profile (BRCA mutations, PARP inhibitor sensitivity, etc.)
• Your prior treatments and how you've responded
• Your disease stage and location of metastases
• Your geographic location

Recommended Resources to Search:

1. ClinicalTrials.gov - The official U.S. database where you can search by:

   • Cancer type: "Prostate Cancer"
   • Status: "Recruiting" or "Active, not recruiting"
   • Your location
   • Specific drug names or trial types

2. NCCN (National Comprehensive Cancer Network) Guidelines - Recommend consulting with a genitourinary (GU) medical oncologist who specializes in prostate cancer, as they have current knowledge of available trials in your area.

3. Your Oncology Team - This is critical. According to Dr. [removed] webinar, having a specialized GU medical oncologist managing your care is essential for identifying appropriate trials.

---

Important Considerations from the Evidence

Genetic Testing First - Before pursuing trials, the webinar emphasizes the importance of comprehensive genomic testing (like Foundation One). This identifies:

• BRCA mutations (which may make you eligible for PARP inhibitor trials)
• Other DNA repair gene mutations
• Specific mutations that determine which trials are appropriate for you

Imaging Matters - The webinar discusses comparing PSMA-PET scans with FDG-PET scans to ensure all your lesions respond to PSMA-targeted therapies before starting certain trials.

Response Monitoring - Different trials monitor response differently. Some use PSA levels, others use imaging, and some use both. Understanding how YOUR trial measures success is important.

---

Questions to Ask Your Oncology Team

1. "Based on my genetic testing results, which clinical trials am I eligible for?"
2. "Are there any trials specifically designed for patients who have progressed on [your current/previous treatment]?"
3. "What is the primary endpoint of the trial you're recommending, and how will we measure if it's working for me?"
4. "Are there trials combining immunotherapy with other approaches that might be appropriate for my case?"
5. "How do I access ClinicalTrials.gov and search for trials near me, and can you help me understand which ones fit my situation?"

---

A Critical Recommendation

The webinar emphasizes that having a specialized genitourinary medical oncologist is crucial for navigating trial options. If you don't currently have one, this should be a priority. Specialists in prostate cancer have current knowledge of available trials and can match your specific case to appropriate options.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about clinical trial eligibility.